Barbara Ann Karmanos Cancer Institute

03/24/2025 | Press release | Archived content

IN THE NEWS: Dr. Zonder on the Need for Increased Awareness in Multiple Myeloma

March 24, 2025

OncLive

Multiple myeloma is one of the most commonly diagnosed hematologic cancers, but as Jeffrey Zonder, M.D., hematologist, leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team (MDT) and member of the Hematology Oncology MDT at Karmanos, explained, many people don't know what it is.

Watch the interview here.